0.9% sodium chloride, GB-0895 clinical trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma

This study is looking for new ways to help adults with severe asthma that isn't well controlled. It tests a new drug, GB-0895, alongside their usual asthma medicine, to see if it reduces severe asthma attacks.